(GMRE) Global Medical REIT - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US37954A2042
GMRE: Healthcare Facilities, Medical Offices, Physician Practices
Global Medical REIT Inc. (GMRE) is a net-lease medical office real estate investment trust (REIT) specializing in the acquisition and ownership of healthcare facilities. These properties are leased to physician groups, regional healthcare systems, and national healthcare providers. The company focuses on strategically located medical office buildings, outpatient facilities, and other healthcare-related real estate. GMREs portfolio is designed to provide stable cash flows through long-term leases with tenants in the healthcare sector. The REITs strategy emphasizes properties with strong tenancy and growth potential in areas with increasing demand for healthcare services.
As of the latest data, GMRE trades on the NYSE under the ticker symbol GMRE, with a market capitalization of approximately $577.96 million. The stock has shown recent price activity around $8.48, with a 20-day average volume of 406,062 shares. On the technical front, the stock is trading near its 20-day simple moving average (SMA) of $8.14, slightly above its 50-day SMA of $7.96, but below its 200-day SMA of $8.60. The average true range (ATR) of $0.19 indicates relatively low volatility in recent trading sessions.
From a fundamental perspective, GMREs forward P/E ratio of 93.46 suggests high expectations for future earnings growth, though the trailing P/E is currently 0.00, which may reflect recent losses or negative earnings. The price-to-book (P/B) ratio of 1.20 indicates that the stock is trading slightly above its book value, while the price-to-sales (P/S) ratio of 4.23 points to a premium valuation relative to its revenue. The return on equity (RoE) of 0.81% highlights modest profitability in generating returns from shareholders equity.
3-Month Forecast: Based on the provided data, GMRE is likely to experience continued volatility within a narrow range, bounded by support near $8.00 (aligned with its 50-day SMA) and resistance at $8.60 (its 200-day SMA). The low ATR of $0.19 suggests that price movements will remain subdued in the near term. However, the high forward P/E ratio of 93.46 indicates that investor expectations for future growth could drive upward momentum if the company delivers strong earnings or announces strategic initiatives. Additionally, any changes in the broader healthcare REIT sector or macroeconomic conditions could influence the stocks performance during this period.
Additional Sources for GMRE Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
GMRE Stock Overview
Market Cap in USD | 1,216m |
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
GiC Sub-Industry | Health Care REITs |
IPO / Inception | 2016-06-29 |
GMRE Stock Ratings
Growth 5y | 6.29% |
Fundamental | 8.25% |
Dividend | 84.0% |
Rel. Strength Industry | -0.67 |
Analysts | 4.1/5 |
Fair Price Momentum | 8.99 USD |
Fair Price DCF | 5.59 USD |
GMRE Dividends
Dividend Yield 12m | 9.77% |
Yield on Cost 5y | 14.17% |
Annual Growth 5y | 0.98% |
Payout Consistency | 95.6% |
GMRE Growth Ratios
Growth Correlation 3m | 60.3% |
Growth Correlation 12m | 12.3% |
Growth Correlation 5y | -32.9% |
CAGR 5y | 7.97% |
CAGR/Max DD 5y | 0.14 |
Sharpe Ratio 12m | 0.99 |
Alpha | -0.32 |
Beta | 0.58 |
Volatility | 23.04% |
Current Volume | 523k |
Average Volume 20d | 432.2k |
As of March 13, 2025, the stock is trading at USD 8.70 with a total of 522,963 shares traded.
Over the past week, the price has changed by -1.69%, over one month by +9.71%, over three months by +5.38% and over the past year by +6.95%.
Neither. Based on ValueRay Fundamental Analyses, Global Medical REIT is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 8.25 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GMRE as of March 2025 is 8.99. This means that GMRE is currently overvalued and has a potential downside of 3.33%.
Global Medical REIT has received a consensus analysts rating of 4.10. Therefor, it is recommend to buy GMRE.
- Strong Buy: 5
- Buy: 1
- Hold: 4
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, GMRE Global Medical REIT will be worth about 9.8 in March 2026. The stock is currently trading at 8.70. This means that the stock has a potential upside of +12.07%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 10.7 | 22.8% |
Analysts Target Price | 10.8 | 24.6% |
ValueRay Target Price | 9.8 | 12.1% |